-
Mashup Score: 2
Jason Bacharach, MD, joins host I. Paul Singh, MD, to discuss a study exploring patient-reported outcomes after switching to or starting a preservative-free latanoprost formulation. As Dr. Bacharach notes in this episode, in addition to contributing to…
Source: eyetube.netCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 0
Building on 75 years of innovation, AbbVie continues its strong investment in eye care.
Source: glaucomatoday.comCategories: General Medicine News, OphthalmologyTweet-
In this article commemorating 75 years of innovation at #AbbVie, learn more about the company’s investment in R&D of different sustained-release platforms and medications, and surgical treatments that may help reduce patients’ reliance on medications. #ad https://t.co/zEsq9S5YCJ https://t.co/2XpcN21RJV
-
-
Mashup Score: 27
I. Paul Singh, MD, shares this teaching video to help other surgeons understand how to address the nasal trabecular meshwork using the OMNI Surgical System (Sight Sciences). Financial Disclosure: Consultant (Sight Sciences)
Source: eyetube.netCategories: General Medicine News, OphthalmologyTweet-
I. Paul Singh, MD, shares this teaching video to help other surgeons understand how to address the nasal trabecular meshwork using the OMNI Surgical System (Sight Sciences). Financial Disclosure: Consultant (Sight Sciences): https://t.co/UwJMMqEPvq https://t.co/kPDSns29bq
-
-
Mashup Score: 3
I. Paul Singh, MD, describes where the MINIject (iStar Medical) supraciliary MIGS device fits into his glaucoma treatment paradigm. He explains the limitations of trabecular meshwork-based MIGS devices and shares his clinical experience with the MINIject,…
Source: eyetube.netCategories: General Medicine News, OphthalmologyTweet-
Dr. I. Paul Singh discusses safety and efficacy, and his own clinical experience with the MINIject supraciliary MIGS device: https://t.co/DNteEZQstl MINIject is an investigational device in the US and not for sale. https://t.co/2eN2jlvNZt
-
-
Mashup Score: 0ViaLase and the John A. Moran Eye Center Announce Research Partnership to Accelerate Glaucoma Research and Innovation - Eyewire+ - 17 day(s) ago
ViaLase announced a research partnership with the John A. Moran Eye Center at the University of Utah (Moran Eye Center), home to the Alan S.
Source: Eyewire NewsCategories: General Medicine News, OphthalmologyTweet-
The collaboration will explore aqueous outflow dynamics of ViaLase’s ViaLase laser procedure, utilizing Moran’s iPerfusion technology: https://t.co/NmntZsgooS https://t.co/w4yvPDUIkt
-
-
Mashup Score: 9Excise and Mobilize: A Bleb Revision Technique - Eyetube - 23 day(s) ago
Austin Bohner, MD, and Craig Chaya, MD, present their preferred surgical bleb revision technique they call “excise and mobilize.” The technique involves removing necrotic tissue and advancing healthy conjunctiva. They say this approach preserves the flap…
Source: eyetube.netCategories: General Medicine News, OphthalmologyTweet-
Austin Bohner, MD, and Craig Chaya, MD, present their preferred surgical bleb revision technique they call "excise and mobilize." The technique involves removing necrotic tissue and advancing healthy conjunctiva. Continue watching here: https://t.co/ccCpOMC8Ai https://t.co/FTsxie9sHv
-
-
Mashup Score: 0
This episode features two articles recently published in Glaucoma Today. First, Shannan Moore, BS, recaps her article—“Is There a Link Between Chronic Stress, Autonomic Dysregulation, and Glaucomatous Progression?”—which was written with Garrick…
Source: eyetube.netCategories: General Medicine News, OphthalmologyTweet-
Shannan Moore, MD, and Mona Kaleem, MD, discuss inquiring about chronic emotional stressors when seeing patients, and review 4 solutions to help overcome challenges associated w/ eye drop administration, respectively: https://t.co/Ypr9vnL2lb https://t.co/X72JOjKKIX
-
-
Mashup Score: 1Xen Gel Stent Revision and Ahmed Valve Implantation - Eyetube - 1 month(s) ago
Manjool Shah, MD, discusses a complicated case with Joseph F. Panarelli, MD, and Arsham Sheybani, MD, in which a patient implanted with a Xen Gel Stent (AbbVie) experienced an IOP spike after 6 months. YAG laser and needling were attempted but were…
Source: eyetube.netCategories: General Medicine News, OphthalmologyTweet-
Dr. Manjool Shah discusses a complicated case in which a patient implanted with a Xen Gel Stent experienced an IOP spike after 6 months. Dr. Shah describes his approach to the revision of the Xen and implantation of an Ahmed Glaucoma Valve. Watch: https://t.co/kCXdxuOpRA https://t.co/hDEftIedI9
-
-
Mashup Score: 4
Nishani Amerasinghe, MBBS, BSc, FRCOphth, sits down with Iqbal Ike K. Ahmed, MD, FRCSC, and Arsham Sheybani, MD, to review 5-year data behind Hydrus Microstent (Alcon) implantation. She shares insights into insertion techniques to help shorten the…
Source: eyetube.netCategories: General Medicine News, OphthalmologyTweet-
In this episode, Dr. Nishani Amerasinghe reviews 5-year data behind Hydrus Microstent implantation, sharing insights into insertion techniques to help shorten the learning curve and improve visualization during the procedure. Watch here: https://t.co/ohA0M8erlO https://t.co/8qX28bnK5q
-
-
Mashup Score: 3A Deep Dive on the iDose® TR Phase 2b Trial - Glaucoma Today - 1 month(s) ago
Sustained efficacy and safety data can help guide clinical decisions.
Source: glaucomatoday.comCategories: General Medicine News, OphthalmologyTweet-
To set clear expectations for patients, surgeons rely on clinical trial data to support treatment decisions. In this article, Dr. Inder Paul Singh reviews the data behind the iDose TR and explains how it can help reduce a patient’s drop burden. Read here: https://t.co/lZf3pt0nZD https://t.co/5Yl3fmjykZ
-
What is the impact of benzalkonium chloride on the long-term health of the eye? According to Jason Bacharach, MD, (of @northbayeye) there are implications beyond just the impact on the ocular surface: https://t.co/MYOa3Ango6 https://t.co/GTvSpBjqNO